Last Updated: August 5, 2026

Patent: 11,607,496

✉ Email this page to a colleague

Summary for Patent: 11,607,496

Title:	Front loaded auto injector for administering a medicament
Abstract:	Disclosed is a method for controlling an auto injector and an auto injector for administering a medicament from a cartridge having a first cartridge end and a second cartridge end and having a cartridge outlet at the first cartridge end, the cartridge comprising a cartridge compartment with a first cartridge subcompartment containing a first medicament component of the medicament and a second cartridge subcompartment containing a second medicament component of the medicament. The auto injector comprises: a housing; a cartridge receiver; a cartridge sensor; a drive module; an orientation sensor; and a processing unit.
Inventor(s):	Paul Erik Fabricius, Jan Olesen, Steen Jensen, Henrik Egesborg, Per Mølgaard Pedersen
Assignee:	Ascendis Pharma AS
Application Number:	US16/060,630
Patent Claims:	see list of patent claims
Patent landscape, scope, and claims summary:	error: insufficient information More… ↓ ⤷ Start Trial

Details for Patent 11,607,496

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Ascendis Pharma Endocrinology Division A/s	SKYTROFA	lonapegsomatropin-tcgd	For Injection	761177	August 25, 2021	⤷ Start Trial	2036-12-29
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

International Patent Family for US Patent 11,607,496

Subscribe to access the full database, or Start Trial
Country	Patent Number	Estimated Expiration
World Intellectual Property Organization (WIPO)	2017114908	⤷ Start Trial
World Intellectual Property Organization (WIPO)	2017114909	⤷ Start Trial
United States of America	11351305	⤷ Start Trial
United States of America	12290663	⤷ Start Trial
United States of America	12296148	⤷ Start Trial
United States of America	2018369481	⤷ Start Trial
>Country	>Patent Number	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.